Synthetic peptide, and cosmetic composition or pharmaceutical composition and application thereof
US-2024352069-A1 · Oct 24, 2024 · US
US10487112B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10487112-B2 |
| Application number | US-201615746596-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 8, 2016 |
| Priority date | Aug 25, 2016 |
| Publication date | Nov 26, 2019 |
| Grant date | Nov 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A Pediococcus acidilactici derived antimicrobial hexapeptide and a preparation method thereof are disclosed herein. The antimicrobial peptide ENGEEE (SEQ ID NO: 1) is reported for the first time. Antimicrobial peptide lactein R16 has good pH stability and thermal stability, has an effect on inhibiting Escherichia coli, Listeria monocytogenes and Staphylococcus aureus and is capable of effectively reducing the amount of the Escherichia coli in soybean meal. Secondly, the antimicrobial peptide lactein R16 has a certain effect on proliferating Saccharomyces cerevisiae and Lactobacillus plantarum and has certain capability of clearing hydrogen peroxide, hydroxyl radicals, DPPH radicals and superoxide anions. The antimicrobial peptide lactein R16 can be used for biological control and can be used as a feed additive to play important roles in substituting antibiotics and solving the feed safety problem.
Opening claim text (preview).
What is claimed is: 1. A composition comprising an antimicrobial peptide consisting of the amino acid sequence of SEQ ID NO: 1, and a soybean meal. 2. The composition of claim 1 , further comprising Escherichia coli. 3. A method of inhibiting bacterial infection in a subject, comprising administering the composition of claim 1 to the subject in need thereof. 4. The method of claim 3 , wherein the bacterial infection is selected from the group consisting of Escherichia coli, Listeria monocytogenes and Staphylococcus aureus.
Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof · CPC title
N-acyl derivatives · CPC title
Microorganisms; Enzymes; {Antibiotics} · CPC title
Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation · CPC title
Polymeric derivatives, e.g. peptides or proteins · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.